Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001643224 | SCV001855808 | benign | not provided | 2019-03-31 | criteria provided, single submitter | clinical testing | |
H3Africa Consortium | RCV001358415 | SCV002014634 | benign | not specified | 2020-10-28 | criteria provided, single submitter | research | While the frequency of the alternate allele in gnoMAD v2.0.2 is 0.229, its frequency in African populations is >5%. This suggests that previous classifications of this variant as pathogenic are in error. |
Central Research Laboratory, |
RCV000498104 | SCV000590805 | pathogenic | Congenital heart disease | 2017-01-07 | no assertion criteria provided | clinical testing | |
Reproductive Health Research and Development, |
RCV000498104 | SCV001142385 | benign | Congenital heart disease | 2020-01-06 | no assertion criteria provided | curation | NG_008177.2(NM_002052.4):c.1147-107A>G in the gene GATA4 has an allele frequency of 0.510 in European (non-Finnish) subpopulation in the gnomAD database. 2668 homozygous occurrences are observed in the gnomAD database. This evidence suggests the variant to be classified as benign. ACMG/AMP criteria applied: BA1; BS2. |
Department of Pathology and Laboratory Medicine, |
RCV001358415 | SCV001554140 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001358415 | SCV001808984 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001358415 | SCV001954593 | benign | not specified | no assertion criteria provided | clinical testing |